RESIDALYA acquired by DOMUSVI

I-Squared Capital entered into a binding agreement to acquire a majority stake in Domidep from its founder and a consortium of minority financial investors (UI Gestion, BNP Paribas Developpement, Bpifrance, and Carvest). This acquisition serves as a cornerstone for the acquirer's European healthcare strategy, with a focus on institutionalizing the group's operations and funding further international expansion into markets such as Germany and Belgium. The deal was supported by a significant senior secured term loan of over EUR400 million, along with equity injections from the new sponsor.

Colisée Group entered into a definitive agreement to acquire 100% of Armonea to create the fourth-largest elderly care operator in Europe. This transformative acquisition doubled Colisée’s size, resulting in a combined entity with a turnover of approximately €1 billion and a network of 270 facilities across five countries. The merger was strategically designed to capitalize on geographic complementarities, merging Colisée’s strong Mediterranean presence with Armonea’s market leadership in Northern Europe. The transaction allowed the founder’s holding company, Jade, to maintain its role as a key minority shareholder with a 19% stake in the newly enlarged group.

Humana AB entered into a definitive agreement to acquire 100% of Coronaria Hoiva Oy to significantly expand its operational footprint in the Finnish market. This strategic acquisition was designed to integrate Coronaria Hoiva’s specialized residential care portfolio into Humana’s existing Finnish operations, creating a more diversified and robust platform for social care delivery. The transaction was financed through a combination of existing cash reserves and new credit facilities, and it received formal approval from the Finnish Competition and Consumer Authority in early April. The move aligned with Humana’s long-term strategy of consolidating the Nordic care market, providing an immediate positive contribution to the group's revenues and earnings per share while enhancing its ability to serve the growing Finnish aging population.

Investindustrial acquired a controlling stake in Lifebrain from the investment vehicle lb EK Management. The deal follows a period of intense growth supported by MCI Capital, during which the group established itself as a leading consolidator in the fragmented Italian laboratory market. The acquisition was structured through a Luxembourg vehicle, European Laboratory Services, and aimed to provide the capital and expertise necessary to professionalize the group and accelerate its aggressive acquisition strategy across Italy.

Pan-European private equity firm Hg has successfully completed the divestiture of its majority equity stake in Swedish care provider Frösunda Omsorg AB to Norway-based investment firm The Adolfsen Group. Executed through the holding company Brado—an investment vehicle owned by brothers Kristian and Roger Adolfsen—the transaction concludes a highly successful eight-year holding period for the sponsor. Throughout the targeted sale process, Hg was exclusively advised by investment bank Carnegie, acting as sole financial advisor. For the acquirer, the buyout represents a strategic opportunity to further consolidate its footprint and deepen its portfolio exposure within the highly resilient Nordic care services sector. For Frösunda, partnering with a long-term, specialized investment group provides the management team with the necessary backing to continue scaling the corporate platform, while remaining fully focused on its core operational mission: delivering premium, critical specialist care to its customers.

Permira acquired I-MED from EQT Mid Market and its co-investors (GIC and CDPQ) in a competitive auction process. The transaction was structured as a majority buyout, with the existing management team, led by CEO Steven Rubic, rolling over equity and remaining at the helm. Under EQT's previous four-year ownership, I-MED had significantly expanded its footprint through hospital contracts and bolt-on acquisitions. Permira's entry was designed to drive the next phase of growth by further consolidating the fragmented Australian radiology market, investing in advanced imaging technologies, and exploring potential international expansion (including teleradiology).

ICG and founder Yves Journel have entered into exclusive negotiations to acquire the majority stake in DomusVi from PAI Partners. The transaction follows a preemptive bid by ICG that successfully bypassed a formal auction process involving major international investors and sovereign funds. This deal marks a significant change in scale for the group, which was valued at less than €650 million in 2014. The acquisition is structured to maintain the existing high-yield bond financing, as the continued presence of ICG and the founder in the capital prevents the activation of change-of-control repayment clauses. The strategic rationale centers on pursuing the international expansion of the group, particularly in markets like Spain, where the recent integration of SARquavitae has already propelled the company to a leadership position. The partnership intends to bridge the gap with major competitors such as Orpea and Korian-Medica by leveraging DomusVi's strong expertise in specialized care and home services.

IK Investment Partners, through its IK VIII Fund, reached an agreement with Eurazeo PME and the management team to acquire a majority stake in Colisée. The founding family and management team reinvested alongside IK, ensuring continuity of strategic direction and operational leadership. The investment thesis centres on supporting Colisée's continued growth through selective buy-and-build acquisitions in France and across Europe, as well as the development of innovative services for elderly people.

Partners Group and Canadian pension fund PSP entered exclusive negotiations to acquire Cerba from PAI Partners. The consortium beat out CVC and Apax, but most notably rejected a higher offer (>EUR2bn) from industrial player Cinven (owner of Synlab/Labco). Management preferred the financial sponsors to avoid massive cost synergies and restructuring.

DomusVi has successfully acquired its Spanish competitor SARquavitae, previously held by a consortium of investment funds including Palamon Capital Partners and G Square Capital. This transformative build-up operation allows the group to become the number one player in the Spanish elderly care market. The strategic rationale centers on geographic diversification, as the target’s strong footprint in Catalonia and Madrid perfectly complements the acquirer’s existing position in Galicia. The integration adds 88 facilities and 11,000 beds to the group’s portfolio, bringing total pro forma revenues to approximately €1.2 billion. This acquisition marks a significant milestone in the group’s international expansion strategy, following the previous year’s integration of another Spanish operator, thereby solidifying its leadership position in Southern Europe.